Microneedle technologies for (trans)dermal drug and vaccine delivery

Journal of Controlled Release

Volumn 161, Issue 2, 2012, Pages 645-655

  Van Der Maaden, Koen ^a   Jiskoot, Wim ^a   Bouwstra, Joke ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

(Trans)dermal drug delivery; Formulation; Microneedles; Protein degradation; Protein delivery; Vaccine delivery

Indexed keywords

FORMULATION; MICRONEEDLES; PROTEIN DEGRADATION; PROTEIN DELIVERY; VACCINE DELIVERY;

DRUG DELIVERY; OLIGONUCLEOTIDES; PROTEINS; VACCINES; VIRUSES;

NEEDLES;

BOVINE SERUM ALBUMIN; INSULIN; VACCINE;

COAT AND POKE; DRUG DELIVERY SYSTEM; GEOMETRY; GOOD MANUFACTURING PRACTICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IONTOPHORESIS; LIQUID CHROMATOGRAPHY; MEDICAL DEVICE; MICRONEEDLE; NEEDLE; NONHUMAN; POKE AND FLOW; POKE AND PATCH; POKE AND RELEASE; PRIORITY JOURNAL; REVIEW; SKIN PENETRATION; TANDEM MASS SPECTROMETRY; TRANSDERMAL DRUG ADMINISTRATION; VACCINATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MICROINJECTIONS; NEEDLES; PROTEINS; VACCINES;

EID: 84862675560     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.01.042     Document Type: Review

References (155)

1. H.J.G.E. Gardeniers, R. Luttge, E.J.W. Berenschot, M.J.d. Boer, S.Y. Yeshurun, M. Hefetz, R.v.t. Oever, A.v.d. Berg, Silicon micromachined hollow microneedles for transdermal liquid transport, J. Microelectromech. Syst. 12 (3) (2003) 855-862.
2. C.D. Chin, V. Linder, S.K. Sia, Lab-on-a-chip devices for global health: past studies and future opportunities, Lab Chip 7 (2007) 41-57.
3. J.G.E. Gardeniers, A.v.d. Berg, Lab-on-a-chip systems for biomedical and environmental monitoring, Anal. Bioanal. Chem. 378 (2004) 1700-1703.
4. K. Tsuchiya, N. Nakanishi, Y. Uetsuji, E. Nakamachi, Development of blood extraction system for health monitoring system, Biomed. Microdevices 7 (4) (2005) 347-353.
5. H.W. Vesper, P.M. Wang, E. Archibold, M.R. Prausnitz, G.L. Myers, Assessment of trueness of a glucose monitor using interstitial fluid and whole blood as specimen matrix, Diabetes Technol. Ther. 8 (1) (2006) 76-80.
6. J.T. Huzil, S. Sivaloganathan, M. Kohandel, M. Foldvari, Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. (2011), doi: 10.1002/wnan.147.
7. J.A. Bouwstra, M. Ponec, The skin barrier in healthy and diseased state, Biochim. Biophys. Acta 1758 (2006) 2080-2095.
8. J. Kanitakis, Anatomy, histology and immunohistochemistry of normal human skin, Eur. J. Dermatol. 12 (4) (2002) 390-399.
9. E.N. Marieb, Human Anatomy & Physiology, Dayl Fox, 2004.
10. S.M. Bal, Z. Ding, E.v. Riet, W. Jiskoot, J. Bouwstra, Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J. Control. Release 148 (3) (2010) 266-282.
11. B. Combadiere, B. Mahe, Particle-based vaccines for transcutaneous vaccination, Comp. Immunol. Microbiol. Infect. Dis. 31 (2-3) (2008) 293-315.
12. T. Warger, H. Schild, G. Rechtsteiner, Initiation of adaptive immune responses by transcutaneous immunization, Immunol. Lett. 109 (7) (2007) 13-20.
13. D.V. McAllister, M.G. Allen, M.R. Prausnitz, Microfabricated microneedles for gene and drug delivery, Annu. Rev. Biomed. Eng. 02 (2000) 289-313.
14. M.R. Prausnitz, Microneedles for transdermal drug delivery, Adv. Drug Deliv. Rev. 56 (5) (2004) 581-587.
15. M.R. Prausnitz, R. Langer, Transdermal drug delivery, Nat. Biotechnol. 26 (11) (2008) 1261-1268.
16. T. Tanner, R. Marks, Delivering drugs by the transdermal route: review and comment, Skin Res. Technol. 14 (3) (2008) 249-260.
17. A.M. Ball, K.M. Smith, Optimizing transdermal drug therapy, Am. J. Health Syst. Pharm. 65 (14) (2008) 1337-1346.
18. G. Chopda, Transdermal Drug Delivery Systems: A Reviewavailable from: http://www.pharmainfo.net/reviews/transdermal-drug-delivery-systems-review 2006.
19. R.K. Subedi, S.Y. Oh, M.-K. Chun, H.-K. Choi, Recent advances in transdermal drug delivery, Arch. Pharm. Res. 33 (3) (2010) 339-351.
20. S. Henry, D.V. McAllister, M.G. Allen, M.R. Prausnitz, Microfabricated microneedles: a novel approach to transdermal drug delivery, J. Pharm. Sci. 87 (8) (1998) 922-925.
21. W.H. Smart, K. Subramanian, The use of silicon microfabrication technology in painless blood glucose monitoring, Diabetes Technol. Ther. 2 (4) (2000) 549-559.
22. M.L. Reed, W.-K. Lye, Microsystems for drug and gene delivery, Proc. IEEE 92 (1) (2004) 56-75.
23. J.D. Zahn, D. Trebotich, D. Liepmann, Microdialysis microneedles for continuous medical monitoring, Biomed. Microdevices 7 (1) (2005) 59-69.
24. E.V. Mukerjee, S.D. Collins, R.R. Isseroff, R.L. Smith, Microneedle array for transdermal biological fluid extraction and in situ analysis, Sens. Actuators A Phys. 114 (2-3) (2004) 267-275.
25. R. Luttge, E.J.W. Berenschot, M.J.d. Boer, D.M. Altpeter, E.X. Vrouwe, A.v.d. Berg, M. Elwenspoek, Integrated lithographic molding for microneedle-based devices, J. Microelectromech. Sys. 16 (4) (2007) 872-884.
26. A. Rodriguez, D. Molinero, E. Valera, T. Trifonov, L.F. Marsal, J. Pallares, R. Alcubilla, Fabrication of silicon oxide microneedles from macroporous silicon, Sens. Actuators B 109 (2005) 135-140.
27. M.R. Prausnitz, H.S. Gill, J.-H. Park, Modified Release Drug Delivery, Vol. 2nd ed, Healthcare, New York, 2008, pp. 295-309.
28. A.K. Banga, Microporation applications for enhancing drug delivery, Expert Opin. Drug Deliv. 6 (4) (2009) 343-354.
29. A. Arora, M.R. Prausnitz, S. Mitragotri, Micro-scale devices for transdermal drug delivery, Int. J. Pharm. 364 (2) (2008) 227-236.
30. T. Miyano, Y. Tobinaga, T. Kanno, Y. Matsuzaki, H. Takeda, M. Wakui, K. Hanada, Sugar micro needles as transdermic drug delivery system, Biomed. Microdevices 7 (3) (2005) 185-188.
31. S.P. Davis, W. Martanto, M.G. Allen, M.R. Prausnitz, Hollow metal microneedles for insulin delivery to diabetic rats, IEEE Trans. Biomed. Eng. 52 (2005) 909-915.
32. J.-H. Park, M.G. Allen, M.R. Prausnitz, Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery, J. Control. Release 104 (1) (2005) 51-66.
33. Y. Ito, J.-I. Yoshimitsu, K. Shiroyama, N. Sugioka, K. Takada, Self-dissolving microneedles for the percutaneous absorption of EPO in mice, J. Drug Target. 14 (5) (2006) 255-261.
34. J.-H. Park, M.G. Allen, M.R. Prausnitz, Polymer microneedles for controlled-release drug delivery, Pharm. Res. 23 (5) (2006) 1008-1019.
35. S.-C. Kuo, Y. Chou, A novel polymer microneedle arrays and pdms micromolding technique, Tamkang, J. Sci. Eng. 7 (2) (2004) 95-98.
36. H. Kalluri, C.S. Kolli, A.K. Banga, Characterization of Microchannels Created by Metal Microneedles: Formation and Closure, AAPS J. (2011), doi: 10.1208/s12248-011-9288-3.
37. J.A. Matriano, M. Cormier, J. Johnson, W.A. Young, M. Buttery, K. Nyam, P.E. Daddona, Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization, Pharm. Res. 19 (1) (2002) 63-70.
38. F. Chabri, K. Bouris, T. Jones, D. Barrow, A. Hann, C. Allender, K. Brain, J. Birchall, Microfabricated silicon microneedles for nonviral cutaneous gene delivery, Br. J. Dermatol. 150 (2004) 869-877.
39. W. Martanto, J.S. Moore, O. Kashlan, R. Kamath, P.M. Wang, J.M. O'Neal, M.R. Prausnitz, Microinfusion using hollow microneedles, Pharm. Res. 23 (1) (2006) 104-113.
40. S.-J. Paik, S. Byun, J.-M. Lim, Y. Park, A. Lee, S. Chung, J. Chang, K. Chun, D.D. Cho, In-plane single-crystal-silicon microneedles for minimally invasive microfluid systems, Sens. Actuators A Phys. 2004 (2004) 276-284.
41. D.V. McAllister, P.M. Wang, S.P. Davis, J.-H. Park, P.J. Canatella, M.G. Allen, M.R. Prausnitz, Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies, Proc. Natl. Acad. Sci. U. S. A. 100 (24) (2003) 13755-13760.
42. B. Stoeber, D. Liepmann, Design, fabrication and testing of a MEMS syringe, Presented at the Solid-State Sensor, Actuator and Microsystems Workshop, Hilton Head, SC, 2002, 2002.
43. R. Sivamani, D. Liepmann, H. Maibach, Microneedles and transdermal applications, Expert Opin. Drug Deliv. 4 (1) (2007) 19-25.
44. M. Cormier, B. Johnson, M. Ameri, K. Nyam, L. Libiran, D.D. Zhang, P. Daddona, Transdermal delivery of desmopressin using a coated microneedle array patch system, J. Control. Release 97 (2004) 503-511.
45. G. Widera, J. Johnson, L. Kim, L. Libiran, K. Nyam, P.E. Daddona, M. Cormier, Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system, Vaccine 24 (2006) 1653-1664.
46. F.J. Verbaan, S.M. Bal, D.J.v.d. Berg, W.H.H. Groenink, H. Verpoorten, R. Lüttge, J.A. Bouwstra, Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin, J. Control. Release 117 (2007) 238-245.
47. F.J. Verbaan, S.M. Bal, D.J.v.d. Berg, J.A. Dijksman, M.v. Hecke, H. Verpoorten, A.v.d. Berg, R. Luttge, J.A. Bouwstra, Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method, J. Control. Release 128 (2008) 80-88.
48. A.J. Harvey, S.A. Kaestner, D.E. Sutter, N.G. Harvey, J.A. Mikszta, R.J. Pettis, Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs, Pharm. Res. 28 (107-116) (2011).
49. E.M. Nadgorny, J. Drelich, Laser-Based Deposition Technique: Patterning Nanoparticles into Microstructures, Dekker Encyclopedia of Nanoscience and Nanotechnology (2004) 1565-1579.
50. K. Migalska, D.I.J. Morrow, M.J. Garland, R. Thakur, A.D. Woolfson, R.F. Donnelly, Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery, Pharm. Res. 28 (2011) 1919-1930.
51. J.W. Lee, J.-H. Park, M.R. Prausnitz, Dissolving microneedles for transdermal drug delivery, Biomaterials 29 (2008) 2113-2124.
52. L.Y. Chu, S.-O. Choi, M.R. Prausnitz, Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: bubble and pedestal microneedle designs, J. Pharm. Sci. 99 (10) (2010) 4228-4238.
53. S.P. Sullivan, D.G. Koutsonanos, M.d.P. Martin, J.W. Lee, V. Zarnitsyn, S.-O. Choi, N. Murthy, R.W. Compans, I. Skountzou, M.R. Prausnitz, Dissolving polymer microneedle patches for influenza vaccination, Nat. Med. 16 (8) (2010) 915-929.
54. K. Fukushima, A. Ise, H. Morita, R. Hasegawa, Y. Ito, N. Sugioka, K. Takada, Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats, Pharm. Res. 28 (2011) 7-21.
55. K. Lee, C.Y. Lee, H. Jung, Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose, Biomaterials 32 (2011) 3134-3140.
56. M.I. Haq, E. Smith, D.N. John, M. Kalavala, C. Edwards, A. Anstey, A. Morrissey, J.C. Birchall, Clinical administration of microneedles: skin puncture, pain and sensation, Biomed. Microdevices 11 (1) (2009) 35-47.
57. P.M. Wang, M. Cornwell, J. Hill, M.R. Prausnitz, Precise microinjection into skin using hollow microneedles, J. Invest. Dermatol. 126 (5) (2006) 1080-1087.
58. R.F. Donnelly, T.R.R. Singh, A.D. Woolfson, Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety, Drug Delivery 17 (4) (2010) 187-207.
59. D.W. Bodhale, A. Nisar, N. Afzulpurkar, Structural and microfluidic analysis of hollow side-open polymeric microneedles for transdermal drug delivery applications, Microfluid. Nanofluid. 8 (3) (2010) 373-392.
60. A.L. Teo, C. Shearwood, K.C. Nga, J. Lua, S. Moochhala, Transdermal microneedles for drug delivery applications, Mater. Sci. Eng. B 132 (2006) 151-154.
61. S.P. Davis, B.J. Landis, Z.H. Adams, M.G. Allen, M.R. Prausnitz, Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force, J. Biomech. 37 (2004) 1155-1163.
62. J.D. Zahn, N.H. Talbot, D. Liepmann, A.P. Pisano, Microfabricated polysilicon microneedles for minimally invasive biomedical devices, Biomed. Microdevices 2 (4) (2000) 295-303.
63. S.-O. Choi, Y.C. Kim, J.-H. Park, J. Hutcheson, H.S. Gill, Y.-K. Yoon, M.R. Prausnitz, M.G. Allen, An electrically active microneedle array for electroporation, Biomed. Microdevices 12 (2) (2010) 263-273.
64. M. Yang, J.D. Zahn, Microneedle insertion force reduction using vibratory actuation, Biomed. Microdevices 6 (3) (2004) 177-182.
65. M.L. Crichton, A. Ansaldo, X. Chen, T.W. Prow, G.J.P. Fernando, M.A.F. Kendall, The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine, Biomaterials 31 (2010) 4562-4572.
66. X. Chen, G.J.P. Fernando, M.L. Crichton, C. Flaim, S.R. Yukiko, E.J. Fairmaid, H.J. Corbett, C.A. Primiero, A.B. Ansaldo, I.H. Frazer, L.E. Brown, M.A.F. Kendall, Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization, J. Control. Release 152 (2011) 349-355.
67. S.M. Bal, J. Caussin, S. Pavel, J.A. Bouwstra, In vivo assessment of safety of microneedle arrays in human skin, J. Control. Release 35 (2008) 193-202.
68. N. Roxhed, B. Samel, L. Nordquist, P. Griss, G. Stemme, Painless drug delivery through microneedle-based transdermal patches featuring active infusion, IEEE Trans. Biomed. Eng. 55 (3) (2008) 1063-1071.
69. S. Chandrasekaran, A.B. Frazier, Mechanical characterization of surface micromachined hollow metallic microneedles, IEEE The Sixteenth Annual International Conference on Micro Electro Mechanical Systems, 2003. MEMS-03 Kyoto, 2002, pp. 363-366.
70. Q. Cui, C. Liu, X.F. Zha, Study on a piezoelectric micropump for the controlled drug delivery system, Microfluid. Nanofluid. 3 (2007) 377-390.
71. M.E. Tucker, Recombinant Human Hyaluronidase Accelerates Insulin Absorption, Internal Medicine News 2011Available from:, http://www. internalmedicinenews.com/search/search-single-view/recombinant-human- hyaluronidase-accelerates-insulin-absorption/978d75e015.html January 10, 2012.
72. G.L. Li, T.J.V. Steeg, H. Putter, J.V.D. Spek, S. Pavel, M. Danhof, J.A. Bouwstra, Cutaneous side-effects of transdermal iontophoresis with and without surfactant pretreatment: a single-blinded, randomized controlled trial, Br. J. Dermatol. 153 (2) (2005) 404-412.
73. H. Kalluri, A.K. Banga, Formation and closure of microchannels in skin following microporation, Pharm. Res. 28 (2011) 82-94.
74. J. Gupta, H.S. Gill, S.N. Andrews, M.R. Prausnitz, Kinetics of skin resealing after insertion of microneedles in human subjects, J. Control. Release (2011), doi: 10.1016/j.jconrel.2011.05.021.
75. S.L. Banks, K.S. Paudel, N.K. Brogden, C.D. Loftin, A.L. Stinchcomb, Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin, Pharm. Res. 28 (5) (2011) 1211-1219.
76. H. Chen, H. Zhu, J. Zheng, D. Mou, J. Wan, J. Zhang, T. Shi, Y. Zhao, H. Xu, X. Yang, Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin, J. Control. Release 139 (2009) 63-72.
77. X.-M. Wu, H. Todo, K. Sugibayashi, Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis, J. Control. Release 118 (2007) 189-195.
78. A.V. Badkar, A.M. Smith, J.A. Eppstein, A.K. Banga, Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats, Pharm. Res. 24 (7) (2007) 1389-1395.
79. S. Katikaneni, A. Badkar, S. Nema, A.K. Banga,Molecular charge mediated transport of a 13 kD protein across microporated skin, Int. J. Pharm. 378 (2009) 93-100.
80. W. Lin, M. Cormier, A. Samiee, A. Griffin, B. Johnson, C.-L. Teng, G.E. Hardee, P.E. Daddona, Transdermal delivery of antisense oligonucleotideswith microprojection patch (Macroflux) technology, Pharm. Res. 18 (12) (2001).
81. J.A. Mikszta, J.B. Alarcon, J.M. Brittingham, D.E. Sutter, R.J. Pettis, N.G. Harvey, Improved genetic immunization via micromechanical disruption of skinbarrier function and targeted epidermal delivery, Nat. Med. 8 (2002) 415-419.
82. C.H. Dean, J.B. Alarcon, A.M. Waterston, K. Draper, R. Early, F. Guirakhoo, T.P. Monath, J.A. Mikszta, Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE in non-human primates, Hum. Vaccin. 1 (3) (2005) 106-111.
83. H.S. Gill, S.N. Andrews, S.K. Sakthivel, A. Fedanov, I.R. Williams, D.A. Garber, F.H. Priddy, S. Yellin, M.B. Feinberg, S.I. Staprans, M.R. Prausnitz, Selective removal of stratum corneum by microdermabrasion to increase skin permeability, Eur. J. Pharm. Sci. 38 (2009) 95-103.
84. M. Pearton, S.-M. Kang, J.-M. Song, Y.-C. Kim, F.-S. Quan, A. Anstey, M. Ivory, M.R. Prausnitz, R.W. Compans, J.C. Birchall, Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin, Vaccine 28 (2010) 6104-6113.
85. J.A. Mikszta, V.J. Sullivan, C. Dean, A.M. Waterston, J.B. Alarcon, J.P.D. III, J.M. Brittingham, J. Huang, C.R. Hwang, M. Ferriter, G. Jiang, K. Mar, K.U. Saikh, B.G. Stiles, C.J. Roy, Robert G. Ulrich, N.G. Harvey, Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms, J. Infect. Dis. 191 (2) (2005) 278-288.
86. P.E. Laurent, H. Bourhy, M. Fantino, P. Alchas, J.A. Mikszta, Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults, Vaccine 28 (2010) 5850-5856.
87. B. Chen, J. Wei, F.E.H. Tay, Y.T. Wong, C. Iliescu, Silicon microneedle array with biodegradable tips for transdermal drug delivery, Microsyst. Technol. 14 (7) (2007) 1015-1019.
88. K. Lee, J.D. Kim, C.Y. Lee, S. Her, H. Jung, A high-capacity, hybrid electromicroneedle for in-situ cutaneous gene transfer, Biomaterials (2011), doi: 10.1016/j.biomaterials.2011.06.058.
89. D. Scholten, M. Stumber, F. Laermer, A. Feyh, Manufacturing method for a porous microneedle array and corresponding porous microneedle array and corresponding substrate composite, United States Patent Application 20110137254 (2011).
90. M.G. Allen, M.R. Prausnitz, D.V. McAllister, F.P.M. Cros, Microneedle Devices and Methods of Manufacture and Use Thereof, US 2010/0312191 A1 (2010).
91. J. Ji, F.E.H. Tay, J. Miao, C. Iliescu, Microfabricated microneedle with porous tip for drug delivery, J. Micromech. Microeng. 16 (5) (2006) 958-964.
92. J.-H. Park, S.-O. Choi, R. Kamath, Y.-K. Yoon, M.G. Allen, M.R. Prausnitz, Polymer particle-based micromolding to fabricate novel microstructures, Biomed. Microdevices 9 (2007) 223-234.
93. M. Shirkhanzadeh, Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalosea, J. Mater. Sci. Mater. Med. 16 (1) (2005) 37-45.
94. H.S. Gill, M.R. Prausnitz, Coating formulations for microneedles, Pharm. Res. 24 (7) (2007) 1369-1380.
95. H.S. Gill, M.R. Prausnitz, Coated microneedles for transdermal delivery, J. Control. Release 117 (2007) 227-237.
96. H.S. Gill, M.R. Prausnitz, Pocketed microneedles for drug delivery to the skin, J. Phys. Chem. Solids 69 (5-6) (2008) 1537-1541.
97. T. Matsuda, M. Mizutani, Liquid acrylate-endcapped biodegradable poly(ε-caprolactone-co-trimethylene carbonate). II. Computer-aided stereolithographic microarchitectural surface photoconstructs, J. Biomed. Mater. Res. 62 (3) (2002) 395-403.
98. R.F. Donnelly, R. Majithiya, T.R.R. Singh, D.I.J. Morrow, M.J. Garland, Y.K. Demir, K. Migalska, E. Ryan, D. Gillen, C.J. Scott, A.D. Woolfson, Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique, Pharm. Res. 28 (1) (2011) 41-57.
99. M.G. McGrath, A. Vrdoljak, C. O'Mahony, J.C. Oliveira, A.C. Moore, A.M. Crean, Determination of parameters for successful spray coating of silicon microneedle arrays, Int. J. Pharm. 415 (2011) 140-149.
100. X. Chen, T.W. Prow, M.L. Crichton, D.W.K. Jenkins, M.S. Roberts, I.H. Frazer, G.J.P. Fernando, M.A.F. Kendall, Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin, J. Control. Release 139 (2009) 212-220.
101. Y. Zhang, K. Brown, K. Siebenaler, A. Determan, D. Dohmeier, K. Hansen, Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action, Pharm. Res. (2011), doi:10.1007/s11095-011- 0524-4.
102. Y. Xie, B. Xu, Y. Gao, Controlled transdermal delivery of model drug compounds by MEMS microneedle array, Nanomedicine 1 (2005) 184-190.
103. H.S. Gill, J. Soderholm, M.R. Prausnitz, M. Salberg, Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine, Gene Ther. 17 (2010) 811-814.
104. E.M. Saurer, R.M. Flessner, S.P. Sullivan, M.R. Prausnitz, D.M. Lynn, Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin, Biomacromolecules 11 (2010) 3136-3143.
105. D.G. Koutsonanos, M.d.P. Martin, V.G. Zarnitsyn, S.P. Sullivan, R.W. Compans, M.R. Prausnitz, I. Skountzou, Transdermal influenza immunization with vaccine-coated microneedle arrays, PLoS One 4 (3) (2009) e4773.
106. F.-S. Quan, Y.-C. Kim, D.-G. Yoo, R.W. Compans, M.R. Prausnitz, S.-M. Kang, Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin, PLoS One 4 (9) (2009) e7215.
107. Q. Zhu, V.G. Zarnitsyn, L. Ye, Z. Wen, Y. Gao, L. Pan, I. Skountzou, H.S. Gill, M.R. Prausnitz, C. Yang, R.W. Compans, Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge, Proc. Natl. Acad. Sci. U. S. A. 106 (19) (2009) 7968-7973.
108. F.-S. Quan, Y.-C. Kim, A. Vunnava, D.-G. Yoo, J.-M. Song, M.R. Prausnitz, R.W. Compans, S.-M. Kang, Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization, J. Virol. 84 (15) (2010) 7760-7769.
109. Y.-C. Kim, F.-S. Quan, R.W. Compans, S.-M. Kang, M.R. Prausnitz, Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity, J. Control. Release 142 (3) (2010) 187-195.
110. Y.-C. Kim, F.-S. Quan, R.W. Compans, S.-M. Kang, M.R. Prausnitz, Formulation of microneedles coated with influenza virus-like particle vaccine, AAPS PharmSciTech 11 (3) (2010) 1193-1201.
111. Y.-C. Kim, F.-S. Quan, D.-G. Yoo, R.W. Compans, S.-M. Kang, M.R. Prausnitz, Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles, J. Infect. Dis. 201 (2) (2010) 190-198.
112. Y.-C. Kim, F.-S. Quan, R.W. Compans, S.-M. Kang, M.R. Prausnitz, Stability kinetics of influenza vaccine coated onto microneedles during drying and storage, Pharm. Res. 28 (1) (2010) 135-144.
113. Y.-C. Kim, F.-S. Quan, D.-G. Yoo, R.W. Compans, S.-M. Kang, M.R. Prausnitz, Improved influenza vaccination in the skin using vaccine coated microneedles, Vaccine 27 (2009) 6932-6938.
114. C.J.B.G.T.J.C. Martin, Aerosol coating of microneedles, WO/2009/081125, , 2009.
115. M. Ameri, P.E. Daddona, Y.-F. Maa, Demonstrated solid-state stability of parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system, Pharm. Res. 26 (11) (2009) 2454-2463.
116. A.K. Andrianov, A. Marin, D.P. DeCollibus, Microneedles with intrinsic immunoadjuvant properties: microfabrication, protein stability, and modulated release, Pharm. Res. 28 (2011) 58-65.
117. A.K. Andrianov, D.P. DeCollibus, H.A. Gillis, H.H. Kha, A. Marin, M.R. Prausnitz, L.A. Babiuk, H. Townsend, G. Mutwiri, Poly[di(carboxylatophenoxy) phosphazene] is a potent adjuvant for intradermal immunization, Proc. Natl. Acad. Sci. U. S. A. 106 (45) (2009) 18936-18941.
118. A. Marin, A.K. Andrianov, Carboxymethylcellulose-chitosan-coated microneedles with modulated hydration properties, J. Appl. Polym. Sci. 121 (2011) 395-401.
119. X. Su, B.-S. Kim, S.R. Kim, P.T. Hammond, D.J. Irvine, Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery, ACS Nano 3 (11) (2009) 3719-3729.
120. P.C. DeMuth, X. Su, R.E. Samuel, P.T. Hammond, D.J. Irvine, Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA, Adv. Mater. 22 (2010) 4851-4856.
121. R.J. Verheul, B. Slütter, S.M. Bal, J.A. Bouwstra,W. Jiskoot,W.E. Hennink, Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination, J. Control. Release (2011), doi:10.1016/j.jconrel.2011.07.014.
122. S.M. Bal, B. Slütter, W. Jiskoot, J.A. Bouwstra, Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation, Vaccine 29 (23) (2011) 4025-4032.
123. S.M. Bal, B. Slütter, E.v. Riet, A.C. Kruithof, Z. Ding, G.F.A. Kersten, W. Jiskoot, J.A. Bouwstra, Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations, J. Control. Release 142 (3) (2010) 374-383.
124. B. Slütter, S.M. Bal, D. Zhi, W. Jiskoot, J.A. Bouwstra, Adjuvant effect of cationic liposomes and CpG depends on administration route, J. Control. Release (2011), doi:10.1016/j.jconrel.2011.02.007.
125. A.P. Raphael, T.W. Prow, M.L. Crichton, X. Chen, G.J.P. Fernando, M.A.F. Kendall, Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays, Small 6 (16) (2010) 1785-1793.
126. A. Kumar, X. Li, M.A. Sandoval, B.L. Rodriguez, B.R. Sloat, Z. Cui, Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedletreated mouse skin, Int. J. Nanomed. 6 (2011) 1253-1264.
127. L. Nordquist, N. Roxhed, P. Griss, G. Stemme, Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration, Pharm. Res. 24 (7) (2007) 1381-1388.
128. J. Gupta, E.I. Felner, M.R. Prausnitz, Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles, Diabetes Technol. Ther. 11 (6) (2009) 329-337.
129. W. Martanto, S.P. Davis, N.R. Holiday, J. Wang, H.S. Gill, M.R. Prausnitz, Transdermal delivery of insulin using microneedles in vivo, Pharm. Res. 21 (6) (2004) 947-952.
130. Y. Wu, Y. Gao, G. Qin, S. Zhang, Y. Qiu, F. Li, B. Xu, Sustained release of insulin through skin by intradermal microdelivery system, Biomed. Microdevices 12 (4) (2010) 665-671.
131. J. Gupta, E.I. Felner, M.R. Prausnitz, Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects, Diabetes Technol. Ther. 13 (4) (2011) 451-456.
132. R.J. Pettis, B. Ginsberg, L. Hirsch, D. Sutter, S. Keith, E. McVey, N.G. Harvey, M. Hompesch, L. Nosek, C. Kapitza, L. Heinemann, Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection, Diabetes Technol. Ther. 13 (4) (2011) 435-442.
133. R.J. Pettis, L. Hirsch, C. Kapitza, L. Nosek, U. Hövelmann, H.-J. Kurth, D.E. Sutter, N.G. Harvey, L. Heinemann, Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes, Diabetes Technol. Ther. 13 (4) (2011) 443-450.
134. S. Hermeling, L. Aranha, J.M.A. Damen, M. Slijper, H. Schellekens, D.J.A. Crommelin, W. Jiskoot, Structural characterization and immunogenicity in immune tolerant mice of recombinant human interferon alpha2b, Pharm. Res. 22 (2005) 1997-2006.
135. S. Hermeling, H. Schellekens, C. Maas, M.F.B.G. Gebbink, D.J.A. Crommelin, W.W. Jiskoot, Antibody response to aggregated human interferon alpha2b in wildtype and transgenic immune tolerant mice depends on type and level of aggregation, J. Pharm. Sci. 95 (2006) 1084-1096.
136. M.M.C.V. Beers, M. Sauerborn, F. Gilli, V. Brinks, H. Schellekens, W. Jiskoot, Oxidized and aggregated recombinant interferon beta is immunogenic in human interferon beta transgenic mice, Pharm. Res. 28 (2011) 2393-2402.
137. Zosano-Pharma, available from:, http://zosanopharma.com/index.php?option= com-content&task=view&id=99&Itemid=139 29-09-2011.
138. NanoPass-Technologies, available from:, http://www.nanopass.com/content- c.asp?cid=22 2011-09-28.
139. J. Gupta, D.D. Denson, E.I. Felner, M.R. Prausnitz, Rapid local anesthesia in humans using minimally invasive microneedles, Clin. J. Pain (2011), doi: 10.1097/AJP.0b013e318225dbe9.
140. X. Li, R. Zhao, Z. Qin, J. Zhang, S. Zhai, Y. Qiu, Y. Gao, B. Xu, S.H. Thomas, Microneedle pretreatment improves efficacy of cutaneous topical anesthesia, Am. J. Emerg. Med. 28 (2010) 130-134.
141. D.P. Wermeling, S.L. Banks, D.A. Hudson, H.S. Gill, J. Gupta, M.R. Prausnitz, A.L. Stinchcomb, Microneedles permit transdermal delivery of a skin-impermeant medication to humans, Proc. Natl. Acad. Sci. U. S. A. 105 (6) (2008) 2058-2063.
142. I. Leroux-Roels, E. Vets, R. Freese, M. Seiberling, F. Weber, C. Salamand, G. Leroux-Roels, Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults, Vaccine 26 (51) (2008) 6614-6619.
143. J. Beran, A. Ambrozaitis, A. Laiskonis, N. Mickuviene, P. Bacart, Y. Calozet, E. Demanet, S. Heijmans, P.V. Belle, F. Weber, C. Salamand, Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial, BMC Med. 7 (13) (2009).
144. P.V. Damme, F. Oosterhuis-Kafeja, M.V.d. Wielen, Y. Almagor, O. Sharon, Y. Levin, Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults, Vaccine 27 (3) (2009) 454-459.
145. S. Hermeling, D.J.A. Crommelin, H. Schellekens, W. Jiskoot, Structure-immunogenicity relationships of therapeutic proteins, Pharm. Res. 21 (6) (2004) 897-903.
146. H. Schellekens, Factors influencing the immunogenicity of therapeutic proteins, Nephrol. Dial. Transplant. (Suppl. 6) (2005) vi3-vi9.
147. H. Schellekens, How to predict and prevent the immunogenicity of therapeutic proteins, Biotechnol. Annu. Rev. 14 (2008) 191-202.
148. M. Sauerborn, V. Brinks, W. Jiskoot, H. Schellekens, Immunological mechanism underlying the immune response to recombinant human protein therapeutics, Trends Pharmacol. Sci. 31 (2) (2010) 53-59.
149. S.K. Singh, Impact of product-related factors on immunogenicity of biotherapeutics, J. Pharm. Sci. 100 (2) (2011) 354-387.
150. T. Arakawa, J.S. Philo, D. Ejima, K. Tsumoto, F. Arisaka, Aggregation analysis of therapeutic proteins, Part 1, BioProcess Int. 4 (10) (2006) 42-43.
151. A.S. Rosenberg, Effects of protein aggregates: an immunologic perspective, AAPS J. 8 (3) (2006) E501-E507.
152. S.K. Singh, N. Afonina, M. Awwad, K. Bechtold-Peters, J.T. Blue, D. Chou, M. Cromwell, H.-J. Krause, H.-C. Mahler, B.K. Meyer, L. Narhi, D.P. Nesta, T. Spitznagel, An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics, J. Pharm. Sci. 99 (8) (2010) 3302-3321.
153. J.d. Engelsman, P. Garidel, R. Smulders, H. Koll, B. Smith, S. Bassarab, A. Seidl, O. Hainzl, W. Jiskoot, Strategies for the assessment of protein aggregates in pharmaceutical biotech product development, Pharm. Res. 28 (4) (2011) 920-933.
154. V. Brinks, W. Jiskoot, H. Schellekens, Immunogenicity of therapeutic proteins: the use of animal models, Pharm. Res. 28 (2011) 2379-2385.
155. J.D. Zahn, D. Trebotich, D. Liepmann, Microfabricated Microdialysis Microneedles for Continuous Medical Monitoring, 2000.